Global In Vitro Diagnostic Market Analysis

The global IVD services industry has been witnessing stupendous growth for past some years owing to increasing prevalence of chronic & infectious diseases, emergence of new technologies and spreading awareness. The technological advancement of diagnostic techniques substantially contributed to the development of IVD services industry which is estimated to have grown by around 8% in 2009 compared to the previous year (2008).

According to our new research report “Global In Vitro Diagnostic Market Analysis”, the year-on-year growth of the global IVD services industry is anticipated to accelerate in near future on the back of strong demand for diagnostics services globally. It is expected that the global IVD market will grow at a CAGR of around 9% during 2010-2012. In this regard, we have done an extensive research and analysis of all the segments of IVD services industry.

Our report has found that the point-of-care segment constitutes a major part of the total IVD services industry. Molecular diagnostics and point of care tests are expected to play an important role in propelling the IVD industry in coming years. The report has also found that the future of this market remains buoyant due to high disposable income and rising healthcare expenditure globally.

The baseline for the optimistic future outlook of our report is that disease tests, blood glucose monitoring and cancer testing segments will dominate the industry in near future. Besides, the influenza diagnostic services are expected to give momentum to the global IVD industry over the forecast period (2010-2012).

Our report contains systematically searched information and reliable statistical data of the global IVD market, with focus on giving brief overview of traditional IVD testing markets and new emerging technological products. The report also gives an insight into prevailing trends in the regional IVD markets across the globe to comprehend the market dynamics. It also contains analysis of market size, growth, share, segmentation and geographic distribution to facilitate clients understand opportunities and challenges before making any investment decision.

The report has carefully examined the IVD market in terms of industrial developments, competitive landscape and regional basis to identify the potential growth segments. Under regional segmentation, the IVD market is classified into North America, Europe and rest of the world.
[Studien Infos ausblenden]

1. Analyst View
2. Research Methodology
3. In Vitro Diagnostic Market Overview
3.1 Introduction
3.2 What is In Vitro Diagnostics?
3.3 Market Size and Growth
4. Market Drivers
4.1 Chronic and Infectious Diseases
4.2 New Technologies
4.3 Emerging Markets
4.4 Diversifying Applications
4.5 Healthcare Infrastructure
5. Clinical Segmentation Outlook 2012
5.1 Point-of-Care Diagnostics
5.2 Clinical Chemistry and Immunochemistry
5.3 Molecular Diagnostics
5.4 Microbiology
5.5 Hemostasis
5.6 Hematology
5.7 Immunohematology
6. Segmentation by Indication (Current and Future Scenario - 2012)
6.1 Diabetes
6.2 Cardiovascular
6.3 Cancer
6.4 HIV
6.5 Tuberculosis
6.6 Influenza
7. Geographical Segmentation (Current and Future Scenario - 2012)
7.1 North America
7.1.1 United States
7.1.2 Canada
7.2 Europe
7.2.1 Germany
7.2.2 France
7.2.3 Italy
7.2.4 United Kingdom
7.2.5 Spain
7.2.6 Other European Countries
7.3 Japan
7.4 Rest of the World
7.4.1 China
7.4.2 India
7.4.3 Turkey
7.4.4 Brazil
7.4.5 Mexico
8. Consumer Behavior Analysis
9. Emerging Sectors
9.1 Companion Diagnostics/Theranostics
9.2 Nanodiagnostics
10. Recent Developments and M&As
11. Industry Restraints
11.1 Regulatory and Reimbursement Issues
11.2 R&D and Short Product Lifecycle
11.3 Cost Control
12. Competitive Landscape
12.1 Market Share of Top Players
12.2 Key Player Profile
12.2.1 Roche Holding Ltd.
12.2.2 Abbott Laboratories
12.2.3 Siemens AG
12.2.4 Beckman Coulter
12.2.5 Ortho-Clinical Diagnostics
[Inhaltsverzeichnis ausblenden]

List of Figures:

Figure 3-1: Global - In Vitro Diagnostic Market (Billion US$), 2008 & 2009
Figure 3-2: Global - Forecast for In Vitro Diagnostic Market (Billion US$), 2010-2012
Figure 5-1: Global - In Vitro Diagnostic Market by Clinical Segment (%), 2009
Figure 5-2: Global - Forecast for In Vitro Diagnostic Market by Clinical Segment (%), 2012
Figure 5-3: Global - Point of Care Diagnostic Market (Billion US$), 2008 & 2009
Figure 5-4: Global - Point of Care Diagnostic Market by Segment (%)
Figure 5-5: Global - Point of Care Diagnostic Market by Distribution (%), 2007
Figure 5-6: Global - Forecast for Point of Care Diagnostic Market (Billion US$), 2010-2012
Figure 5-7: Global - Clinical Chemistry and Immunochemistry Market (Billion US$), 2007-2009
Figure 5-8: Global - Forecast for Clinical Chemistry and Immunochemistry Market (Billion US$), 2010-2012
Figure 5-9: Global - Molecular Diagnostic Market (Billion US$), 2007-2009
Figure 5-10: Global - Forecast for Molecular Diagnostic Market (Billion US$), 2010-2012
Figure 5-11: Global - Microbiology Diagnostic Market (Billion US$), 2008 & 2009
Figure 5-12: Global - Forecast for Microbiology Diagnostic Market (Billion US$), 2010-2012
Figure 5-13: Global - Hemostasis Diagnostic Market (Billion US$), 2008 & 2009
Figure 5-14: Global - Forecast for Hemostasis Diagnostic Market (Billion US$), 2010-2012
Figure 5-15: Global - Forecast for Hematology Market (Billion US$), 2010-2012
Figure 5-16: Global - Immunohematology Diagnostic Market (Billion US$), 2007-2009
Figure 5-17: Global - Forecast for Immunohematology Diagnostic Market (Billion US$), 2010-2012
Figure 6-1: Global - Forecast for Diabetic Population (Million), 2010 & 2030
Figure 6-2: Global - Blood Glucose Monitoring Market (Billion US$), 2007-2009
Figure 6-3: Global - Forecast for Blood Glucose Monitoring Market (Billion US$), 2010-2012
Figure 6-4: Global - Cardiovascular Diagnostic and Therapies Market (Billion US$), 2007-2009
Figure 6-5: Global - Forecast for Cardiovascular Diagnostic and Therapies Market (Billion US$), 2010-2012
Figure 6-6: Global - Cancer Diagnostic Market (Billion US$), 2008 & 2012
Figure 6-7: Global - HIV Diagnostic and Monitoring Market (Million US$), 2004, 2008 & 2012
Figure 6-8: Global - Tuberculosis Diagnostic Market by Segment (%)
Figure 6-9: Global - Tuberculosis Detection and Monitoring Market by Segment (%), 2005
Figure 6-10: Global - Influenza Diagnostic Market (Million US$), 2008-2012
Figure 7-1: Global - In Vitro Diagnostic Market by Region (%), 2009
Figure 7-2: Global - Forecast for In Vitro Diagnostic Market by Region (%), 2012
Figure 7-3: US - In Vitro Diagnostic Market (Billion US$), 2007-2009
Figure 7-4: US - In Vitro Diagnostic Market by Segment (%), 2007
Figure 7-5: US - Labs in IVD Market by Type (%), 2008
Figure 7-6: US - Forecast for In Vitro Diagnostic Market (Billion US$), 2010-2012
Figure 7-7: Canada - In Vitro Diagnostic Market (Million US$), 2007-2009
Figure 7-8: Canada - Forecast for In Vitro Diagnostic Market (Million US$), 2010-2012
Figure 7-9: Europe - In Vitro Diagnostic Market (Billion Euro), 2007-2009
Figure 7-10: Europe - In Vitro Diagnostic Market by Country (%), 2008
Figure 7-11: Europe - Forecast for In Vitro Diagnostic Market (Billion Euro), 2010-2012
Figure 7-12: Germany - In Vitro Diagnostic Market (Million Euro), 2007-2009
Figure 7-13: Germany - Forecast for In Vitro Diagnostic Market (Million Euro), 2010-2012
Figure 7-14: France - In Vitro Diagnostic Market (Million Euro), 2007-2009
Figure 7-15: France - In Vitro Diagnostic Reagents Market by Segment (%)
Figure 7-16: France - Forecast for In Vitro Diagnostic Market (Million Euro), 2010-2012
Figure 7-17: Italy - In Vitro Diagnostic Market (Million Euro), 2007-2009
Figure 7-18: Italy - In Vitro Diagnostic Market by Segment (%), 2008
Figure 7-19: Italy - In Vitro Diagnostic Reagents Market by Segment (%), 2008
Figure 7-20: Italy - Forecast for In Vitro Diagnostic Market (Million Euro), 2010-2012
Figure 7-21: UK - In Vitro Diagnostic Market (Million Euro), 2007-2009
Figure 7-22: UK - Forecast for In Vitro Diagnostic Market (Million Euro), 2010-2012
Figure 7-23: Spain - In Vitro Diagnostic Market (Million Euro), 2007-2009
Figure 7-24: Spain - Forecast for In Vitro Diagnostic Market (Million Euro), 2010-2012
Figure 7-25: Japan - In Vitro Diagnostic Market (Billion Yen), 2007-2009
Figure 7-26: Japan - In Vitro Diagnostic Market by Segment (%), 2007
Figure 7-27: Japan - Share of Players in In Vitro Diagnostic Market
Figure 7-28: Japan - Forecast for In Vitro Diagnostic Market (Billion Yen), 2010-2012
Figure 7-29: China - In Vitro Diagnostic Market (Million US$), 2007-2009
Figure 7-30: China - In Vitro Diagnostic Market by Segment (%), 2007
Figure 7-31: China - Forecast for In Vitro Diagnostic Market (Million US$), 2010-2012
Figure 7-32: India - In Vitro Diagnostic Market (Million US$), 2007-2009
Figure 7-33: India - In Vitro Diagnostic Market by Segment (%), 2007
Figure 7-34: India - Forecast for In Vitro Diagnostic Market (Million US$), 2010-2012
Figure 7-35: Turkey - In Vitro Diagnostic Market (Million US$), 2006-2009
Figure 7-36: Turkey - Share of Clinical Laboratories by Type
Figure 7-37: Turkey - Forecast for In Vitro Diagnostic Market (Million US$), 2010-2012
Figure 7-38: Brazil - In Vitro Diagnostic Market (Million US$), 2007-2009
Figure 7-39: Brazil - In Vitro Diagnostic Market by Segment (%), 2007
Figure 7-40: Brazil - Forecast for In Vitro Diagnostic Market (Million US$), 2010-2012
Figure 7-41: Mexico - In Vitro Diagnostic Market (Million US$), 2007-2009
Figure 7-42: Mexico - In Vitro Diagnostic Market by Segment (%), 2007
Figure 7-43: Mexico - Forecast for In Vitro Diagnostic Market (Million US$), 2010-2012
Figure 11-1: Global - R&D Expenditure on IVD in Comparison to Other Industrial Sectors (%)
Figure 12-1: Global - In Vitro Diagnostic Market by Player (%)
Figure 12-2: Roche Holding Ltd. - Diagnostic Division Revenues by Segment (%), 2009
Figure 12-3: Abbott Laboratories - Diagnostics Product Sales (Million US$), 2007-2009
Figure 12-4: Siemens AG - Diagnostic Division Revenues by Segment (%)
Figure 12-5: Beckman Coulter - Clinical Diagnostics Revenues by Segment (%), 2009

List of Tables:

Table 3-1: Commonly Used In Vitro and In Vivo Diagnostic Tests
Table 5-1: Global - In Vitro Diagnostic Market by Clinical Segment (Billion US$), 2009
Table 5-2: Global - Forecast for In Vitro Diagnostic Market by Clinical Segment (Billion US$), 2012
Table 5-3: Global - Share of Top Players in Clinical Chemistry and Immunochemistry Market (2009)
Table 5-4: Global - Share of Top Players in Molecular Diagnostic Market (2009)
Table 5-5: Global - Share of Top Players in Microbiology Diagnostic Market (2009)
Table 5-6: Global - Share of Top Players in Hemostasis Diagnostic Market (2009)
Table 6-1: Global - Leading Companies in Diabetes Equipment Sales (Billion US$)
Table 6-2: Global - Cancer Diagnostic Market by Type (Million US$), 2006-2008
Table 7-1: Germany - In Vitro Diagnostic Market by Segment (Million Euro), 2008
Table 7-2: Other European Countries - In Vitro Diagnostic Market (Million Euro), 2008
Table 12-1: Roche Holding Ltd. - Strengths & Weaknesses
Table 12-2: Abbott Laboratories - Strengths & Weaknesses
Table 12-3: Siemens AG - Strengths & Weaknesses
Table 12-4: Beckman Coulter - Strengths & Weaknesses
Table 12-5: Ortho-Clinical Diagnostics - Strengths & Weaknesses
[Tabellenverzeichnis ausblenden]